Top News

Sep 21, 2016
The House Committee on Oversight and Government Reform questioned Heather Bresch during a hearing on the company’s decision to raise the price of EpiPen more than 400%.
Sep 20, 2016
By Pharmaceutical Technology Editors
Walmsley will succeed Andrew Witty as CEO of the British drug maker.
Sep 19, 2016
The agency granted accelerated approval to Sarepta’s controversial DMD treatment, under the condition the company conduct additional studies to demonstrate efficacy.
Sep 07, 2016
By Pharmaceutical Technology Editors
The department gave Moderna $8.2 million to accelerate development of an mRNA-based Zika vaccine.
Aug 29, 2016
By Pharmaceutical Technology Editors
The company will launch a generic version of EpiPen at the price of $300 for a two-pack.
Aug 26, 2016
By Pharmaceutical Technology Editors
The initiative targets countries with less developed and evolving healthcare systems such as Latin America, South East Asia, and Africa.
Aug 25, 2016
Ranking members of the Senate Judiciary Committee called on Mylan to explain its decision to raise the price of EpiPens nearly 400%.
Aug 24, 2016
By Pharmaceutical Technology Editors
The portfolio in this agreement include approved antibiotics Merrem, Zinforo, and Zavicefta, as well as candidates in clinical development, ATM-AVI and CXL.
Aug 22, 2016
By Pharmaceutical Technology Editors
Pfizer will acquire Medivation for approximately $14 billion.
Aug 19, 2016
The legal battle between the Broad institute and UC Berkeley heated up after an email was released from a former graduate student.
native1_300x100
lorem ipsum